|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01715 AI HEALTH TECH
Nominal 
0.570 +0.040 (+7.547%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | -- | -- | 91,885 | 84,369 | 88,186 | 143,873 |
| Cost of Sales | -- | -- | (85,400) | (63,152) | (49,699) | (78,603) |
| Gross Profit | -- | -- | 6,485 | 21,217 | 38,487 | 65,270 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (4,024) | (5,715) | (2,059) | (129) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | -- | -- | (342) | (566) | (393) | (736) | |
| Profit / (Loss) before Taxation | -- | -- | (35,958) | (49,283) | (43,206) | (43,720) | |
| Taxation | -- | -- | (47) | (35) | (344) | (174) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | -- | -- | 155 | 0 | 337 | (459) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (35,561) | -0.806% | (35,850) | (49,318) | (43,213) | (44,353) | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | -- | -- | 4,157 | 7,703 | 5,002 | 1,419 |
| Depreciation & Amortisation | -- | -- | 4,238 | 5,514 | 7,205 | 6,811 |
| Directors' Emoluments | -- | -- | 662 | 1,417 | 1,502 | 1,441 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified (Modified Report) | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -13.000 | -59.846% | -32.375 | -63.875 | -63.000 | -64.750 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.364) | 0.216 | (1.265) | (0.007) |
| NBV per share ($) | -- | -- | 0.312 | 0.674 | 1.17196 | 1.812242 |
| Remarks: | Real time quote last updated: 01/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -35,561 |
| %Change | -0.806% |
| EPS / (LPS) | RMB -0.130 |
| NBV Per Share (¥) | RMB -- |